Our partners
The Gene Therapy Innovation and Manufacturing Centre (GTIMC) brings together partners from the North of England, the Midlands and Wales.Â
The Gene Therapy Innovation and Manufacturing Centre (GTIMC) has been formed as part of the . The Innovation Hubs for Gene Therapies include ourselves, the GTIMC in Sheffield, the at King's College London, Royal Free, UCL Gene Therapy Hub () and at NHS Blood and Transplant, Filton ().
Our partners include:
- Cell & Gene Therapy Catapult
- Centre of Process Innovation (CPI)
- º£½ÇÉçÇø of Birmingham
- º£½ÇÉçÇø of Liverpool
- The Midlands-Wales Advanced Therapies Treatment Centre [MW-ATTC]
- º£½ÇÉçÇø of Leeds
- º£½ÇÉçÇø of Leicester
- º£½ÇÉçÇø of York
- Cardiff º£½ÇÉçÇø
- iMatch
- º£½ÇÉçÇø of Bradford
- Northern Health Science Alliance (NHSA)
- NHS Hospital Trusts of Sheffield, Leeds, Birmingham Women’s and Children Hospital
- Leeds Teaching Hospitals NHS Foundation Trust
- Genomic Laboratory Hubs
- Lonza AG
- Advanced Manufacturing Research Centre (AMRC)
- National Horizons Centre (NHC)
- National Institute for Biological Standards
- South Yorkshire Mayoral Combined Authority
- Sheffield Children Hospital
- º£½ÇÉçÇø College London
- º£½ÇÉçÇø of Cambridge
The GTIMC will align with the new Accelerating Research & Development for Advanced Therapies () consortium to enhance global regulatory harmonisation, biobanking and safety of advanced therapies.
Partner with us
We are proud to work in collaboration with a number of charities, global institutes and leading global organisations and seek new and exciting opportunities to further enhance our translational research.
By working together we believe we can find novel solutions to the biggest rare disease challenges and help to change lives.
To work with us contact Prof. Mimoun Azzouz
